35 Results for "

C3a

" in MedChemExpress (MCE) Product Catalog:
Products (35)

35 Results for "C3a" in MCE Product Catalog:

34
34 Publications Verification
Cat. No.: HY-101502A
CAS No.: 1140525-25-2
Purity:  99.82%
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

SB290157 trifluoroacetate is a potent and selective C3a receptor antagonist with an IC50 of 200 nM.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-138161
CAS No.: 2411440-41-8
Purity:  99.59%
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

JR14a is a potent thiophene antagonist of human complement C3a receptor. JR14a shows selectivity for the human C3a receptor over C5a receptor. JR14a can suppress C3aR-mediated inflammation .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-P7863
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rMuComplement C3/C3a; Complement Component C3a; Anaphylatoxin; C3a
Species:  
Source:  
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15978
CAS No.: 1235481-90-9
Target:  

Others

Research Areas:  

Neurological Disease

P7C3-A20 is a derivative of P7C3 with potent proneurogenic and neuroprotective activity. P7C3-A20 exerts an antidepressant-like effect. P7C3-A20 can cross the blood-brain barrier and therefore has the potential for brain injury treatment [3].
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-P7862
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuComplement C3/C3a; Complement Component C3a; C3a; Anaphylatoxin
Species:  
Source:  
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-44170
CAS No.: 902614-04-4
Target:  

PANK

Pantothenate kinase-IN-2 is a pantothenate kinase inhibitor with IC50 values of 92 nM for PanK2, 70 nM for PanK1β, and 25 nM for PanK3. Pantothenate kinase-IN-2 can bind specifically to the ATP-PanK3 complex and block CoA biosynthesis. Pantothenate kinase-IN-2 can be used for the research of pank-associated neurodegeneration and type 2 diabetes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128132
CAS No.: 944997-60-8
Purity:  98.16%
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

C3a receptor agonist 1 (compound benzeneacetamide) is a potent C3a receptor agonist. C3a receptor agonist 1 has the potential for the research of acute inflammation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1505A
Synonyms: Complement 3a (70-77) TFA
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

C3a (70-77) TFA (Complement 3a (70-77) TFA) is an octapeptide corresponding to the COOH terminus of C3a, exhibits the specificity and 1 to 2% biologic activities of C3a .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-138802
CAS No.: 1306638-12-9
Purity:  99.86%
ML089 is an orally active inhibitor of phosphomannose isomerase (PMI) and PHOSPHO1, with an IC50 value of 1.3 μM against human PMI and an IC50 value of 0.8 μM against PHOSPHO1. ML089 blocks the catabolism of mannose-6-phosphate, directs mannose-6-phosphate to participate in protein glycosylation, increases mannose incorporation into cellular proteins, and reduces tritiated water production from mannose-6-phosphate. ML089 inhibits PMI in living cells. ML089 can be used in research related to congenital disorder of glycosylation type Ia (CDG-Ia) .
loading...
    loading...
Cat. No.: HY-159509
CAS No.: 2361124-03-8
Synonyms: Claziprotamide; BBP-671
Target:  

PANK

Claziprotamidum (Claziprotamide; BBP-671) is a panthothenate kinase (PANK) activator with oral activity and blood-brain barrier permeability. Claziprotamidum binds to and activates all PANK isoforms, with the highest affinity for PANK3 (KD = 97 pM; IC50 = 1.39 nM). Claziprotamidum increases the intracellular biosynthesis of Coenzyme A (HY-128851) and restores mitochondrial function. Claziprotamidum can be used in the research of pantothenate kinase-associated neurodegeneration and propionic acidemia [3].
loading...
    loading...
Cat. No.: HY-W683760
CAS No.: 16543-55-8
Synonyms: (2S)-N'-Nitrosonornicotine
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

N-Nitrosonornicotine is a tobacco-specific nitrosamine that has carcinogenic and mutagenic activity, and it can induce micronuclei in C3A cells. N-Nitrosonornicotine can form DNA adducts .
loading...
    loading...
Cat. No.: HY-P1640
CAS No.: 130154-64-2
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

(Trp63,Trp64)​-​C3a(63-77) is a C3a synthetic analogue peptide, which exhibits Ca 2+ stimulating efficacy in human neutrophils and hC3aR or mC3aR expressing RBL-2H3 cells with EC50 of 9.5, 2.0 and 0.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-P1505
CAS No.: 63555-63-5
Synonyms: Complement 3a (70-77)
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

C3a (70-77) is an octapeptide corresponding to the COOH terminus of C3a, exhibits the specificity and 1 to 2% biologic activities of C3a.
loading...
    loading...
Cat. No.: HY-164909
CAS No.: 2170608-85-0
Target:  

PANK

Research Areas:  

Metabolic Disease

PZ-3022 is an orally active allosteric agonist of pantothenate kinase (PanK) with an EC50 of 5.3 nM against PanK3. PZ-3022 antagonizes the inhibitory effect of C3-CoA. PZ-3022 increases CoA levels in cells and the liver, upregulates CoASH and C2-CoA, downregulates C3-CoA, and restores impaired TCA cycle and mitochondrial function. PZ-3022 can be used for the research of propionic acidemia and metabolic CoA deficiency .
loading...
    loading...
Cat. No.: HY-W130878
CAS No.: 1806-26-4
4-Octylphenol is a hormone disruptor that has gender-specific effects on male reproductive cells, significantly reducing the mitotic index and the number of spermatogonia. 4-Octylphenol can cause inflammatory damage to fish gills by activating the complement system through the C3a/C3aR axis and the C5a/C5aR1 axis, this leads to complement activation and causes immune suppression due to the imbalance between Th1/Th2 cells and regulatory T cells (Treg)/Th17 cells, as well as inflammatory damage via the Toll-like receptor 7 (Toll-like Receptor (TLR))/IκBα/NF-κB pathway .
loading...
    loading...
Cat. No.: HY-119051
CAS No.: 1037092-93-5
Target:  

Others

Research Areas:  

Others

BR111 is a C3a protein receptor ligand (pKi = 6.3 nM and Ki = 544 nM) .
loading...
    loading...
Cat. No.: HY-170867
Nrf2/HO-1 activator 3 (Compound C3a) is the activator for Nrf2 signaling pathway that promotes the Nrf2 translocation into nuclei and upregulates the expression of heme oxygenase-1 HO-1. Nrf2/HO-1 activator 3 inhibits the overespression of ROS and MDA in H2O2- or glucose-stimulated H9c2 cardiomyocytes, inhibits the cell viability and colony formation, thereby exhibiting antioxidant efficacy .
loading...
    loading...
Cat. No.: HY-W743781
CAS No.: 1426174-36-8
Synonyms: (2S)-N'-Nitrosonornicotine-d4
N-Nitrosonornicotine-d4 ((2S)-N'-Nitrosonornicotine-d4) is deuterium labeled N-Nitrosonornicotine. N-Nitrosonornicotine is a tobacco-specific nitrosamine that has carcinogenic and mutagenic activity, and it can induce micronuclei in C3A cells. N-Nitrosonornicotine can form DNA adducts .
loading...
    loading...
Cat. No.: HY-W324220
CAS No.: 849021-37-0
Target:  

11β-HSD

Research Areas:  

Metabolic Disease

11β-HSD1-IN-10 (compound c3a) is a potent 11β-HSD1 inhibitor (IC50=1.8 µM for human). 11β-HSD1-IN-10 can be used in studies of obesity, hyperglycemia and cognitive impairment .
loading...
    loading...
Cat. No.: HY-116295
CAS No.: 7077-89-6
MRS2690 is a selective P2Y14 receptor agonist. MRS2690 inhibits adenylyl cyclase activity, thereby reducing intracellular cAMP levels and mediating concentration-dependent vasoconstriction of porcine coronary arteries. MRS2690 induces intracellular calcium mobilization, activates P38 and stimulates [ 35S]GTPγS binding to RBL-2H3 cell membranes. MRS2690 enhances antigen (NP-BSA)-, C3a-induced β-hexosaminidase (β-Hex) release. MRS2690can be used for ischemic heart disease [3] .
loading...
    loading...